TAK

TAK Stock-Based Compensation

¥74.43BTTM · JPY

Period ending:

TAK FY Stock-Based CompJPY
TAK FY Stock-Based Comp2000-03-31: ¥0.002001-03-31: ¥0.002002-03-31: ¥0.002003-03-31: ¥0.002004-03-31: ¥0.002005-03-31: ¥0.002006-03-31: ¥0.002007-03-31: ¥0.002008-03-31: ¥0.002009-03-31: ¥0.002010-03-31: ¥0.002011-03-31: ¥0.002012-03-31: ¥0.002013-03-31: ¥0.002014-03-31: ¥0.002015-03-31: ¥0.002016-03-31: ¥0.002017-03-31: ¥15.39B2018-03-31: ¥18.61B2019-03-31: ¥20.08B2020-03-31: ¥29.12B2021-03-31: ¥37.66B2022-03-31: ¥43.37B2023-03-31: ¥60.67B2024-03-31: ¥70.87B2025-03-31: ¥72.87B2026-03-31: ¥72.78B¥72.87B¥0.00
2000-03-312026-03-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in JPY. Dates are period ends; a fiscal year may differ from a calendar year.

TAK stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 27 observations from Mar 31, 2000 to Mar 31, 2026.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) Stock-Based Compensation — Annual fiscal periods (JPY)
Period endingStock-Based Compensation (JPY)
72,775,000,000
72,867,000,000
70,871,000,000
60,672,000,000
43,374,000,000
37,663,000,000
29,122,000,000
20,084,000,000
18,610,000,000
15,385,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Compare stock-based compensation

All TAK financial metrics · TAK stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.